Form 8-A12B - Registration of securities [Section 12(b)]:
SEC Accession No. 0001193125-20-249136
Filing Date
2020-09-18
Accepted
2020-09-18 16:23:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 8-A12B d31596d8a12b.htm 8-A12B 13812
  Complete submission text file 0001193125-20-249136.txt   14769
Mailing Address 7318 MORTON STREET DALLAS TX 75209
Business Address 7318 MORTON STREET DALLAS TX 75209 212.551.8702
Taysha Gene Therapies, Inc. (Filer) CIK: 0001806310 (see all company filings)

EIN.: 843199512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-A12B | Act: 34 | File No.: 001-39536 | Film No.: 201184264
SIC: 2836 Biological Products, (No Diagnostic Substances)